July 9, 2012 12:26 pm by Stephanie Baum | 0 Comments
Phase 3 trials are underway for a biotechnology company’s drug to treat non-infectious Uveitis, an inflammatory eye disease and the fourth leading cause of blindness among the working age population ...
Read more